IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
The First Affiliated Hospital of Nanchang University
Shandong Cancer Hospital and Institutemonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the The First Affiliated Hospital of Nanchang University cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Orelabrutinib Shandong Cancer Hospital and Institute | Phase 2 | CCC |
Epirubicin Shandong Cancer Hospital and Institute | Phase 2 | CCC |
VINDESINE Shandong Cancer Hospital and Institute | Phase 2 | CCC |
(+)-VINCRISTINE Shandong Cancer Hospital and Institute | Phase 2 | CCC |
Inno-206 Shandong Cancer Hospital and Institute | Phase 2 | CCC |
PREDNISONE TABLETS Shandong Cancer Hospital and Institute | Phase 2 | CCC |
Cyclophosphamide Shandong Cancer Hospital and Institute | Phase 2 | CCC |
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →